Global Tigit Inhibitor Drug Opportunity And Clinical Research Insight 2022

Submitted by Smith Ben | December 22, 2021, 11:28:26 | Technology

T-cell immunoreceptor with Ig and ITIM domains (TIGIT) is one of the most recently identified immune checkpoint inhibitor which is being evaluated as potential immunotherapeutic target. TIGIT is transmembrane glycoprotein receptor with Ig-like V-type domain and an ITIM in its cytoplasmic domain and is expressed on wide range of cells including memory T-cells, NK cells, and Tregs. Apart from this, studies have demonstrated high expression of TIGIT on wide range of solid tumors and hematological malignancies, thus making it potential target in drug development.

Article source:

Tag: #life sciences industry report #tigit inhibitor market research report

You May Like More:

Psd To Shopify Conversion Services – Cartcoders

At Cartcoders, We are the best PSD to Shopify Theme Conversion Service Provider. We are providing fully-functional, Customized Shopify Themes Development Services to our customers and clients. We transform the….

Soothing Neck And Shoulder Massager

A one-stop shop for trending electronics, bluetooth headphones, bluetooth speakers, wireless earbuds, mobile accessories, trending gadgets and more!

Open-source | Better Solution For Better Software Experience.

Being the leading open-source company, we believe that using an open development model helps create more stable, secure and innovative technologies. We have designed resources to help you learn more….

Canon Pixma Ts6320 Download Driver | Ts6320 Inkjet Printer |

The Canon ts6320 setup allows the printer to print files for transfer. And when it comes to quality, the user doesn’t have to worry about it; The Canon TS6320 is….

Your email address will not be published. Required fields are marked *